Immunogenic self-peptides - the great unknowns in autoimmunity: Identifying T-cell epitopes driving the autoimmune response in autoimmune diseases.

HLA association T cell receptor (TCR) T-cell epitope autoimmunity immunogenic self-peptides immunopeptidome polyspecificity psoriais

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2022
Historique:
received: 14 11 2022
accepted: 12 12 2022
entrez: 26 1 2023
pubmed: 27 1 2023
medline: 28 1 2023
Statut: epublish

Résumé

HLA-associated autoimmune diseases likely arise from T-cell-mediated autoimmune responses against certain self-peptides from the broad HLA-presented immunopeptidomes. The limited knowledge of the autoimmune target peptides has so far compromised the basic understanding of autoimmune pathogenesis. This is due to the complexity of antigen processing and presentation as well as the polyspecificity of T-cell receptors (TCRs), which pose high methodological challenges on the discovery of immunogenic self-peptides. HLA-class I molecules present peptides to CD8

Identifiants

pubmed: 36700227
doi: 10.3389/fimmu.2022.1097871
pmc: PMC9868241
doi:

Substances chimiques

Epitopes, T-Lymphocyte 0
Peptides 0
Receptors, Antigen, T-Cell 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1097871

Informations de copyright

Copyright © 2023 Prinz.

Déclaration de conflit d'intérêts

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2428-33
pubmed: 14983026
Genes Immun. 2014 Sep;15(6):347-54
pubmed: 24871463
Genome Biol. 2017 Apr 27;18(1):76
pubmed: 28449694
Nat Genet. 2013 Feb;45(2):202-7
pubmed: 23291587
Nat Immunol. 2002 Dec;3(12):1169-76
pubmed: 12436109
J Invest Dermatol. 2022 Mar;142(3 Pt B):750-759
pubmed: 34294386
Nat Genet. 2010 Jun;42(6):508-14
pubmed: 20453842
Nature. 1988 Aug 4;334(6181):395-402
pubmed: 3043226
J Immunol. 2002 Apr 1;168(7):3649-59
pubmed: 11907131
Nat Commun. 2020 Sep 21;11(1):4767
pubmed: 32958743
J Biol Chem. 2012 Jan 6;287(2):1168-77
pubmed: 22102287
Science. 2016 Oct 21;354(6310):354-358
pubmed: 27846572
Hum Immunol. 2013 Sep;74(9):1134-40
pubmed: 23777927
J Clin Invest. 2017 Aug 1;127(8):2881-2891
pubmed: 28762987
Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18425-30
pubmed: 16339897
Am J Hum Genet. 2006 May;78(5):827-851
pubmed: 16642438
Mol Cell Proteomics. 2022 Jul;21(7):100230
pubmed: 35395404
Genes Immun. 2004 May;5(3):151-7
pubmed: 14749714
Cancer Sci. 2019 Jan;110(1):40-51
pubmed: 30375705
Nat Genet. 2011 Jul 10;43(8):761-7
pubmed: 21743469
Nucleic Acids Res. 2020 Jan 8;48(D1):D948-D955
pubmed: 31667505
Nat Med. 2012 May;18(5):824-8
pubmed: 22484809
Expert Rev Proteomics. 2017 Sep;14(9):729-736
pubmed: 28756714
Nat Genet. 2016 Jul;48(7):740-6
pubmed: 27213287
Br J Dermatol. 1986 Apr;114(4):465-72
pubmed: 2421756
Nature. 1994 Mar 17;368(6468):215-21
pubmed: 8145819
Front Immunol. 2018 Jul 25;9:1716
pubmed: 30090105
Nat Rev Immunol. 2011 Nov 11;11(12):823-36
pubmed: 22076556
Front Med (Lausanne). 2018 Aug 14;5:226
pubmed: 30155467
Eur J Immunol. 1999 Oct;29(10):3360-8
pubmed: 10540348
Immunol Rev. 2012 Nov;250(1):82-101
pubmed: 23046124
Cell Mol Life Sci. 2011 May;68(9):1491-502
pubmed: 21387144
J Clin Invest. 1998 Dec 15;102(12):2082-9
pubmed: 9854043
J Immunol. 2017 Oct 15;199(8):2639-2651
pubmed: 28904123
Trends Biochem Sci. 2014 Jan;39(1):17-24
pubmed: 24286712
Nat Methods. 2021 Aug;18(8):873-880
pubmed: 32632239
Nat Methods. 2021 Aug;18(8):881-892
pubmed: 34282327
Immunol Today. 1998 Sep;19(9):395-404
pubmed: 9745202
Genome Med. 2017 May 24;9(1):44
pubmed: 28539110
Science. 2004 Apr 23;304(5670):587-90
pubmed: 15001714
Proc Natl Acad Sci U S A. 2022 Jul 19;119(29):e2119736119
pubmed: 35858315
J Biol Chem. 2016 Mar 11;291(11):5576-5595
pubmed: 26740625
Elife. 2018 Aug 28;7:
pubmed: 30152754
Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9282-6
pubmed: 7937756
Annu Rev Immunol. 2001;19:375-96
pubmed: 11244041
Proc Natl Acad Sci U S A. 2006 Aug 8;103(32):12057-62
pubmed: 16882720
Nature. 2011 Aug 10;476(7359):214-9
pubmed: 21833088
Front Immunol. 2013 Dec 26;4:485
pubmed: 24421780
N Engl J Med. 2012 Dec 20;367(25):2419-26
pubmed: 23252527
J Immunol. 2004 Nov 1;173(9):5610-6
pubmed: 15494511
Tissue Antigens. 1997 Jan;49(1):35-40
pubmed: 9027963
Science. 1992 Mar 6;255(5049):1261-3
pubmed: 1546328
Nat Genet. 2010 Nov;42(11):985-90
pubmed: 20953190
J Immunol. 2009 Mar 15;182(6):3335-41
pubmed: 19265109
CA Cancer J Clin. 1976 Mar-Apr;26(2):119-21
pubmed: 816431
Nucleic Acids Res. 2015 Jan;43(Database issue):D405-12
pubmed: 25300482
Cell. 2014 May 22;157(5):1073-87
pubmed: 24855945
Mol Cell Proteomics. 2018 Dec;17(12):2347-2357
pubmed: 30171158
J Mol Biol. 2003 Feb 28;326(4):1157-74
pubmed: 12589760
J Exp Med. 2001 Jul 2;194(1):1-12
pubmed: 11435468
J Immunol Methods. 2008 Jul 20;336(1):37-44
pubmed: 18448115
J Immunol Methods. 1996 Jun 10;192(1-2):149-55
pubmed: 8699011
PLoS One. 2012;7(5):e37338
pubmed: 22649519
Front Immunol. 2018 Jul 18;9:1638
pubmed: 30072991
Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8569-71
pubmed: 8710911
Nat Rev Immunol. 2010 Jan;10(1):73-8
pubmed: 20010787
J Immunol. 2021 Nov 1;207(9):2235-2244
pubmed: 34580106
F1000Res. 2015 Aug 03;4:460
pubmed: 26594339
Mol Cell Proteomics. 2015 Mar;14(3):658-73
pubmed: 25576301
J Autoimmun. 2022 Dec;133:102901
pubmed: 36115212
J Exp Med. 2015 Dec 14;212(13):2203-12
pubmed: 26621454
Eur J Immunol. 2004 Feb;34(2):598-607
pubmed: 14768065
Nat Biotechnol. 2021 Feb;39(2):236-245
pubmed: 32895550
Curr Opin Immunol. 2016 Jun;40:70-7
pubmed: 27018930
Immunity. 2011 Nov 23;35(5):681-93
pubmed: 22101157
Nat Rev Immunol. 2015 Apr;15(4):203-16
pubmed: 25720354
J Invest Dermatol. 2018 Jun;138(6):1338-1347
pubmed: 29288651
Sci Immunol. 2019 Aug 16;4(38):
pubmed: 31420320
Nature. 2002 Oct 3;419(6906):480-3
pubmed: 12368856
Hum Immunol. 2019 May;80(5):296-301
pubmed: 30849449
Nat Biotechnol. 2018 Nov 12;:
pubmed: 30418433
J Immunol Methods. 2002 Sep 1;267(1):79-97
pubmed: 12135802
Sci Immunol. 2018 Oct 12;3(28):
pubmed: 30315122
Immunogenetics. 1995;41(4):178-228
pubmed: 7890324
Front Immunol. 2018 Aug 23;9:1924
pubmed: 30190721
Nat Immunol. 2002 Dec;3(12):1177-84
pubmed: 12436110
Nat Immunol. 2019 Dec;20(12):1692-1699
pubmed: 31745340
Nat Rev Immunol. 2008 Aug;8(8):607-18
pubmed: 18641646
Nature. 2004 Jan 15;427(6971):252-6
pubmed: 14724640
Nat Med. 2017 Apr;23(4):501-507
pubmed: 28263308
Immunity. 2015 Jan 20;42(1):95-107
pubmed: 25601203
Nat Immunol. 2019 May;20(5):652-662
pubmed: 30858620
J Allergy Clin Immunol. 2016 Jul;138(1):274-276.e6
pubmed: 26782974
PLoS Biol. 2004 Apr;2(4):E90
pubmed: 15094798
Sci Transl Med. 2010 Sep 1;2(47):47ra64
pubmed: 20811043
J Invest Dermatol. 1998 Apr;110(4):388-92
pubmed: 9540980
Br J Dermatol. 2021 Dec;185(6):1209-1220
pubmed: 34254298
Nature. 1989 Dec 7;342(6250):692-6
pubmed: 2594067

Auteurs

Jörg Christoph Prinz (JC)

Department of Dermatology, University Clinics, Ludwig-Maximilian-University of Munich, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH